Curious about LyondellBasell (LYB) Q2 Performance? Explore Wall Street Estimates for Key Metrics

LyondellBasell (LYB) is anticipated to report a significant Q2 earnings decline, with EPS projected at $0.87 per share (down 61.2% year-over-year) and revenues at $7.41 billion (down 29.9%). Analysts have recently revised the consensus EPS estimate 3.3% lower, a crucial indicator of potential negative investor sentiment and short-term stock performance, particularly as the company holds a Zacks Rank #5 (Strong Sell). This weak outlook is underscored by expected substantial revenue and EBITDA contractions across key segments like Olefins & Polyolefins and Intermediates & Derivatives.

Analysis

LyondellBasell (LYB) faces significant headwinds heading into its Q2 earnings report, with consensus analyst estimates indicating a severe contraction in financial performance. Projections point to a 61.2% year-over-year decline in earnings per share to $0.87 and a 29.9% drop in revenues to $7.41 billion. Reinforcing this negative outlook, the consensus EPS estimate has been revised downward by 3.3% over the past 30 days, a key indicator that often precedes negative short-term stock performance. The weakness appears systemic across the company's segments, with particularly sharp declines anticipated in the Intermediates & Derivatives division, where EBITDA is forecast to plummet from $794.00 million to $253.36 million. The Olefins & Polyolefins-Americas segment is also expected to see its EBITDA more than halved. This fundamental deterioration is underscored by the stock's recent 2.1% gain, which has underperformed the S&P 500 composite's 3.4% move, and a Zacks Rank #5 (Strong Sell), signaling expectations for continued near-term underperformance.

Key Decisions for Investors

• Given the strongly negative analyst consensus and recent downward earnings revisions, investors should exercise extreme caution, as the stock is positioned for a negative reaction to its upcoming earnings release.
• It is prudent to monitor the performance of the Intermediates & Derivatives and Olefins & Polyolefins-Americas segments, as any results worse than the already low EBITDA expectations could trigger a significant sell-off.
• Considering the Zacks Rank #5 (Strong Sell) and broad-based weakness across all key metrics, investors might consider reducing exposure or hedging existing long positions ahead of the report to mitigate potential downside risk.